Jubilant Life Sciences to raise Rs 2,000 crore through redeemable NCDs

10 Sep 2014 Evaluate

Drug firm Jubilant Life Sciences has received its shareholders’ approval to raise Rs 2,000 crore through redeemable non-convertible debentures (NCDs) on a private placement basis or rights basis in one or more tranches. Additionally, the borrowing through debentures will be within the above overall borrowing limit of Rs 5,000 crore.

Jubilant Life Sciences is engaged in manufacture and supply of active pharmaceutical ingredient (APIs), solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients. It also provides services in contract manufacturing of sterile injectables and ointments, creams and liquids and drug discovery and development.

Jubilant Pharmova Share Price

1051.70 -22.60 (-2.10%)
29-Dec-2025 14:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1715.00
Dr. Reddys Lab 1266.30
Cipla 1494.00
Zydus Lifesciences 904.10
Lupin 2081.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×